Immunoassays are easy to run, but the path to develop these tests can be tricky. To make your own reliable, sensitive, and specific ELISA tests requires knowledge of immunology and protein chemistry, not to mention an understanding of all the different components of the test (buffers, stabilizers, stop solutions, diluents, and more). To optimize your… Read more »
Our Magic Red products have been cited in two journals this winter. In the first article, ICT’S Magic Red Cathepsin L Assay was used to measure cathepsin L activation in human aortic endothelial cells. Weikel KA, Cacicedo JM, Ruderman NB, Ido Y. Glucose and palmitate uncouple AMPK from autophagy in human aortic endothelial cells. 2015. J. Cell Physio. doi:10.1152/ajpcell.00265.2014 [Abstract]… Read more »
FLICA Caspase Assay kits have been cited in at least 15 peer-reviewed journal articles this month! Two featured citations: Suschak, JJ, Wang, S, Fitzgerald, KA, Lu, S. (2015). Identification of Aim2 as a Sensor for DNA Vaccines. J. Immunol. vol 194 no. 2 630-636. [Abstract] “Samples were then stained with a caspase-1 FAM/FLICA kit according… Read more »
Two articles have recently been published in the Journal of Cell Science and mBio, an open access journal published by the American Society for Microbiology, citing our Magic Red Cathepsin B Assay Kits (ICT# 937, 938). Li, K, Yang, L, Zhang, C, Niu, Y, Wei, L, Liu, J. (2014). HPS6 interacts with dynactin p150Glued to mediate retrograde… Read more »
Researchers at the University of British Columbia Department of Microbiology and Immunology recently published an article in the Journal of Immunology using our FLICA 660 Caspase 3/7 kit (ICT# 9125).
Our FLICA® Caspase-1 Assay Kits have recently been cited in two research publications involving studies of the inflammatory response after microbial infection.
The first study, authored by researchers at the Utrecht University Department of Infectious Diseases and Immunology, studied a pathogen that causes foodborne disease and gastroenteritis, Campylobacter jejuni.
20 Years of Solutions
ImmunoChemistry Technologies would like to express our gratitude to our customers, partners, and collaborators for their support over the past two decades. Cheers!
Founded in 1994, ImmunoChemistry Technologies has grown to become a strong and growing biotechnology company with a loyal and ever-expanding customer base working in biomedical research labs all over the world.
Research on anticancer potential of imidazolium-based ionic salts reveals four compounds with nanomolar toxic potency against human cancer cell lines
Congratulations to our customers at the Frederick National Laboratory for Cancer Research and the Universidad Metropolitana School of Environmental Affairs for publishing their recent study of the effects of imidazolium-based compounds on 60 human cancer cell lines in the September 2014 issue of MedChemComm.
Lee and Hed douse themselves in ice water to bring awareness to ALS and medical research, challenge industry colleagues
August 27, 2014 – BLOOMINGTON, Minn. — Challenge accepted! Dr. Brian Lee and Ms. Sally Hed, co-owners of ImmunoChemistry Technologies, were nominated to complete the ALS Ice Bucket Challenge. They accepted the challenge on this sunny day in August and made a donation to the ALS Association.
ICT has introduced over 200 recombinant proteins for use as ELISA standards and other research and development applications.